Taylor Stacy L 4
4 · Adaptive Biotechnologies Corp · Filed Aug 23, 2024
Insider Transaction Report
Form 4
Taylor Stacy L
SVP and General Counsel
Transactions
- Sale
Common Stock
2024-08-22$4.50/sh−26,922$121,079→ 139,365 total
Footnotes (2)
- [F1]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 23, 2024.
- [F2]The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $4.415 to $4.62, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.